Blog Archives

Large genetic map of psychiatric disorders completed

March 15, 2020 –  An international study published in the journal Cell has described 109 genetic variants associated with eight psychiatric disorders such as autism, ADHD, schizophrenia, bipolar disorder, depression, obsessive-compulsive disorder and Tourette syndrome in a total of about 230,000 patients worldwide.  

Read more ›

Tags: , , , , , , , , , , , , , ,

Abilify MyCite, the first digital pill. Where does all that silicone go?

November 16, 2017 – The American Food & Drug Administration (FDA) just approved Ability MyCite,  a pill with a sensor that digitally tracks if patients have ingested their medication. This is a very first in its class at the new age of digital health.

Read more ›

Tags: , , , , , , , , , ,

DRESS: Rare but serious skin reaction with Zyprexa (Olanzapine)

May 11, 2016 – We do learn from a very recent Drug Safety Communication (DSC) by the American Food & Drug Administration (FDA) that olanzapine, the pharmacologically active component in Zyprexa, Zyprexa Zydis, Zyprexa Relprevv, Symbyax,

Read more ›

Tags: , , , , , , , , ,

Cariprazine (Vraylar): New treatment for schizophrenia and bipolar disorder approved

 September 19, 2015 – The American Food and Drug Administration (FDA) just approved Cariprazine (Vraylar) capsules to treat schizophrenia and bipolar disorder in adults.

Schizophrenia is a chronic, severe and disabling brain disorder affecting about one percent of Americans. Typically, symptoms are first seen in adults younger than 30 years of age and include hearing voices or seeing things that are not there,

Read more ›

Tags: , , , , ,

Brexpiprazole (Rexulti): A new drug to treat schizophrenia and as an add on to an antidepressant to treat major depressive disorder approved by the FDA

July 19, 2015 – Very recently, the U.S. Food and Drug Administration (FDA) approved Brexpiprazole (Rexulti) tablets to treat adults with schizophrenia and as an add-on treatment to an antidepressant medication to treat adults with major depressive disorder (MDD).

Read more ›

Tags: , , ,

Drug Safety Communication: Asenapine Maleate [Saphris] Associated with Serious Allergic Reactions

September 01, 2011 – Asenapine Maleate [Saphris] is used to treat symptoms of schizophrenia and bipolar disorder. The American Food and Drug Administration (FDA) has notified healthcare professionals and patients that serious allergic reactions have been reported with the use of Asenapine Maleate [Saphris]. The Contraindications,

Read more ›

Tags: , , ,

thasso: conditions

thasso: newest tweets

thasso: recent comments

View my Flipboard Magazine.

thasso: categories

thasso: archives

thasso: simple chat

You must be a registered user to participate in this chat.

  • New type of taste cell discovered in taste buds August 13, 2020
    Our mouths may be home to a newly discovered set of multi-tasking taste cells that—unlike most known taste cells, which detect individual tastes—are capable of detecting sour, sweet, bitter and umami stimuli. A research team led by Kathryn Medler at the University at Buffalo reports this discovery in a study published 13th August in PLOS […]
  • Researchers discover genetic link to predict positive response to immunotherapy in patient August 13, 2020
    A Singapore team led by clinician-scientists and researchers from the National Cancer Centre Singapore (NCCS) discovered a genetic link to better predict treatment response for relapsed/refractory patients with natural-killer T-cell lymphoma (NKTCL), a highly aggressive form of blood cancer. The team performed whole-genome sequencing, to identify mutation in PD-L1 gene as a reliable biomarker to […]
  • Evolution and everyday stress have led to disproportionate suffering among women August 13, 2020
    We're 100% behind knowledge-based research, but sometimes you really do have to question evolution!
  • A cancer mystery more than 40 years old is solved thanks to epigenetics August 12, 2020
    Before the first oncogene mutations were discovered in human cancer in the early 1980s, the 1970s provided the first data suggesting alterations in the genetic material of tumors. In this context, the prestigious journal Nature published in 1975 the existence of a specific alteration in the transformed cell: an RNA responsible for carrying an amino […]
  • Combining genetic information with EMRs to pinpoint childhood epilepsies August 11, 2020
    A team of researchers at Children's Hospital of Philadelphia (CHOP) affiliated with the CHOP Epilepsy Neurogenetics Initiative (ENGIN) further bridged the gap between genomic information and clinical outcome data by systematically linking genetic information with electronic medical records, focusing on how genetic neurological disorders in children develop over time. The findings were published today in […]
  • Employers reject transgender people August 13, 2020
    Employers in Sweden more often reject job applications from transgender people -- especially in male-dominated occupations. Moreover, transgender people face discrimination from two different grounds for discrimination. This is according to a study from Linköping University that was recently published in the journal Labour Economics.
  • How a protein stops cells from attacking their own DNA August 13, 2020
    Scientists at EPFL have demonstrated the mechanism that allows cells to fight off viral DNA without triggering an immune response against their own genetic material.
  • Global deaths due to smokeless tobacco are up by a third, according to new study August 13, 2020
    The number of deaths globally due to smokeless tobacco has gone up by a third in 7 years to an estimated 350,000 people, a new study suggests.
  • A watershed moment for US water quality August 13, 2020
    A new federal rule that determines how the Clean Water Act is implemented leaves millions of miles of streams and acres of wetlands unprotected based on selective interpretation of case law and a distortion of scientific evidence, researchers say in a new publication.
  • Study: Medical marijuana associated with fewer hospitalizations for individuals with SCD August 13, 2020
    Individuals with sickle cell disease (SCD) who receive medical marijuana to treat pain may require fewer visits to the hospital, according to a new study in Blood Advances. Adults with SCD who requested and obtained medical marijuana were admitted to the hospital less frequently than those who did not obtain it.
Top